Disodium clodronate | |
---|---|
Trade Name | |
Orphan Indication | Hypercalcemia of malignancy |
USA Market Approval | USA |
USA Designation Date | 1993-06-16 00:00:00 |
Sponsor | Discovery Experimental & Development, Inc.;29949 S.R. 54 West;Wesley Chapel, Florida, 33543 |